AD

AMY DEMSKE

BRISTOL-MYERS SQUIBB COMPANY · WASHINGTON, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
1
3 agencies contacted
Activity
filings by quarter
Works on

Background

Career
WASHINGTON, DC
2024 - present

Specific issues

Discussions regarding promoting health equity International Reference Pricing/Most Favored Nation, regarding all bio-pharmaceutical issues Ensuring Pathway Implementation of Inflation Reduction Act of 2022 MINI Act H.R. 8412, Clinical Trial Modernization Act S.652/H.R.2630, Safe Step Act Mental health issues Biosimilars reimbursement issues
Health Issues · 2024 Q3

Clients

$██,███ / qtrUnlock

Filing history

2024 Q3
BRISTOL-MYERS SQUIBB COMPANY
Q3lda.gov →
Showing recent filings · full history on lda.gov